Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to greater adverse effects such as drowsiness, although the clinical relevance is low for most individuals – monitor the affected individual for adverse effects (e.The goal of this review was to evaluate the anxiolytic, seda